WG
TARO

Winton Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Winton Group’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7,343
Closed -$307K – 914
2023
Q4 		$307K Buy
7,343
+198
+3% +$7.3K 0.02% 534
2023
Q3 		$269K Buy
+7,145
New +$268K 0.02% 581

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Winton Group's TARO Position: Q1 2024 in Review

Winton Group sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2024, closing a stake of 7,343 shares — an estimated $307K sold.

Winton Group first reported a position in TARO in Q3 2023 and held it in 2 quarters. The position peaked at $307K in Q4 2023. 94 funds tracked by Wall St. Rank hold TARO as of Q1 2024.

  • Winton Group reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2024 after selling out during the quarter.
  • Winton Group sold 7,343 Taro Pharmaceutical Industries Ltd. shares in Q1 2024, an estimated $307K.
  • Winton Group first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2023 and held it in 2 quarters.
  • Winton Group's Taro Pharmaceutical Industries Ltd. position peaked at $307K in Q4 2023.
  • 94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2024.

Based on Winton Group's 13F filing for Q1 2024, filed 14 May 2024.